Global Hemorrhoid Therapy Devices Market Size By Type (Band Ligators, Sclerotherapy Injectors), By Application (Hospitals And Clinics, Ambulatory Surgical Centers), By Region, And Segment Forecasts, 2...

The Global Hemorrhoid Therapy Devices Market was valued at USD 810 million in 2023 and is expected to surpass USD 1.36 billion by 2031, growing at a CAGR of 6.8% during the forecast period from 2023 to 2031. The market's expansion is primarily driven by the increasing prevalence of hemorrhoidal disorders globally, rising geriatric population, and growing demand for minimally invasive treatments. Hemorrhoid therapy devices are widely used for procedures such as rubber band ligation, infrared coagulation, and sclerotherapy, offering effective outpatient solutions with reduced recovery time.

Drivers:

Rising Incidence of Hemorrhoids:

Sedentary lifestyles, poor dietary habits, and aging populations have led to a noticeable increase in hemorrhoid cases worldwide. This growing patient base is significantly fueling the demand for advanced treatment devices.

Preference for Minimally Invasive Procedures:

Patients and healthcare providers increasingly prefer non-surgical and outpatient therapies due to shorter recovery periods and reduced complications. Devices such as infrared coagulators and doppler-guided ligation systems are witnessing strong demand.

Technological Advancements in Therapy Devices:

Continual innovation in hemorrhoid treatment equipment, including portable and user-friendly devices, is enhancing treatment efficacy and patient comfort, thereby supporting market growth.

Restraints:

High Cost of Advanced Devices:

While newer devices offer greater efficacy, their higher costs can deter widespread adoption, especially in low- and middle-income countries where healthcare budgets are constrained.

Limited Awareness in Developing Regions:

Inadequate awareness of hemorrhoid treatments and the availability of modern devices among patients and healthcare providers in some regions may restrict market penetration.

Opportunity:

Expansion in Emerging Healthcare Markets:

Rapid urbanization, rising disposable incomes, and healthcare infrastructure development in Asia-Pacific and Latin America present lucrative opportunities for market players.

Telemedicine and Homecare Integration:

The growth of remote healthcare solutions and at-home medical devices opens up potential for portable hemorrhoid therapy equipment tailored for clinical and personal use.

Market by System Type Insights:

Based on system type, the Infrared Coagulation Devices segment accounted for the largest share in 2023. These devices are widely used due to their non-invasive nature, ease of use, and effectiveness in outpatient settings. The segment is projected to retain its dominance owing to ongoing technological improvements and increasing adoption in ambulatory surgical centers.

The Rubber Band Ligation Devices segment is also gaining traction, particularly due to its cost-effectiveness and high success rates for treating internal hemorrhoids.

Market by End-use Insights:

In terms of end-use, Hospitals emerged as the largest contributor in 2023, accounting for over 45% of the total market share. Their dominance is attributed to access to skilled professionals and advanced surgical equipment. Meanwhile, the Ambulatory Surgical Centers (ASCs) segment is expected to witness the fastest growth, driven by the increasing shift toward outpatient care and reduced treatment costs.

Market by Regional Insights:

Regionally, North America led the global hemorrhoid therapy devices market in 2023, supported by high healthcare spending, awareness levels, and widespread adoption of minimally invasive treatments. However, Asia-Pacific is poised for the highest growth rate during the forecast period due to improving healthcare infrastructure, a growing elderly population, and increasing healthcare awareness in countries like China and India.

Competitive Scenario:

Key players operating in the global hemorrhoid therapy devices market include:

Medtronic plc

Cook Medical

Boston Scientific Corporation

Medline Industries, LP

J&J (Ethicon Inc.)

Sklar Surgical Instruments

Ultroid Technologies, Inc.

Privi Medical

The Prometheus Group

These companies are focusing on product development, regional expansion, and strategic collaborations to enhance their market footprint. For instance:

In 2023, Boston Scientific launched a next-generation bipolar hemorrhoid ligator device to expand its surgical solutions portfolio.

Medtronic introduced a portable hemorrhoid treatment system tailored for outpatient use in early 2024.

Scope of Work – Global Hemorrhoid Therapy Devices Market

Key Market Developments:

2023: Cook Medical announced the FDA clearance of its latest hemorrhoid ligation system for internal hemorrhoids with a disposable applicator.

2024: Privi Medical received CE Mark for its next-gen disposable hemorrhoid device designed for single-use in clinical settings.

2025: Sklar Surgical Instruments expanded its manufacturing capacity to support global demand for hemorrhoid and proctology surgical tools.

FAQs:

1. What is the current market size of the Global Hemorrhoid Therapy Devices Market?

The market was valued at USD 810 million in 2023.

2. What is the major growth driver of the Global Hemorrhoid Therapy Devices Market?

The market is primarily driven by the rising prevalence of hemorrhoidal disorders and increasing demand for minimally invasive treatment options.

3. Which is the largest region during the forecast period in the Global Hemorrhoid Therapy Devices Market?

North America held the largest market share in 2023.

4. Which segment accounted for the largest market share in Global Hemorrhoid Therapy Devices Market?

The Infrared Coagulation Devices segment accounted for the largest market share by system type.

5. Who are the key market players in the Global Hemorrhoid Therapy Devices Market?

Key players include Medtronic plc, Cook Medical, Boston Scientific Corporation, Medline Industries, and Privi Medical.